Page last updated: 2024-08-17

prednisone and biricodar

prednisone has been researched along with biricodar in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beer, TM; Bubley, G; Dalton, WS; Einstein, A; Ette, E; Garg, V; Harding, MW; Henner, WD; Ko, YJ; Lush, R; Merica, EA; Rago, RP	1

Trials

1 trial(s) available for prednisone and biricodar

Article	Year
Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer. Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:4 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Piperidines; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms; Pyridines; Quality of Life; Treatment Outcome	2003

Article

Year

Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer.

Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:4

Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Piperidines; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms; Pyridines; Quality of Life; Treatment Outcome

2003